Biovie Total Current Liabilities vs Operating Income Analysis

Stocks . USA . 
Stock . Biovie Inc
BIVI Stock  USD 2.71  0.11  3.90%   
Biovie financial indicator trend analysis is way more than just evaluating Biovie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biovie Inc is a good investment. Please check the relationship between Biovie Total Current Liabilities and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Total Current Liabilities vs Operating Income

Total Current Liabilities vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biovie Inc Total Current Liabilities account and Operating Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Biovie's Total Current Liabilities and Operating Income is -0.08. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Operating Income in the same time period over historical financial statements of Biovie Inc, assuming nothing else is changed. The correlation between historical values of Biovie's Total Current Liabilities and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Biovie Inc are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Total Current Liabilities i.e., Biovie's Total Current Liabilities and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.08
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Current Liabilities

Total Current Liabilities is an item on Biovie balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biovie Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Operating Income

Operating Income is the amount of profit realized from Biovie Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Biovie Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Biovie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biovie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
As of now, Biovie's Selling General Administrative is increasing as compared to previous years. The Biovie's current Issuance Of Capital Stock is estimated to increase to about 66.9 M, while Enterprise Value Over EBITDA is forecasted to increase to (0.03).
 2021 2022 2024 (projected)
Interest Expense2.2M4.3M1.5M
Depreciation And Amortization237.4K266.8K193.4K

Biovie fundamental ratios Correlations

Total Assets
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Accounts Payable
Cash
Cash And Short Term Investments
Common Stock Total Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Other Current Liab
Net Tangible Assets
Common Stock Shares Outstanding
Non Current Assets Total
Non Currrent Assets Other
Good Will
Other Current Assets
Intangible Assets
Short Long Term Debt Total
Property Plant And Equipment Net
Net Invested Capital
Net Working Capital
Total Assets
0.450.73-0.79-0.920.510.951.0-0.330.520.930.611.0-0.230.040.730.680.12-0.070.520.33-0.120.78-0.480.890.84
Total Current Liabilities
0.45-0.23-0.22-0.40.320.360.43-0.350.170.360.920.44-0.330.88-0.220.790.19-0.060.440.60.090.32-0.470.05-0.08
Total Stockholder Equity
0.73-0.23-0.72-0.690.410.730.74-0.070.20.72-0.10.730.03-0.640.990.17-0.03-0.050.22-0.15-0.210.52-0.130.940.96
Net Debt
-0.79-0.22-0.720.87-0.85-0.91-0.790.31-0.17-0.89-0.28-0.790.180.16-0.76-0.68-0.020.09-0.41-0.310.24-0.50.32-0.87-0.82
Retained Earnings
-0.92-0.4-0.690.87-0.62-0.95-0.920.4-0.45-1.0-0.54-0.920.31-0.04-0.7-0.69-0.110.08-0.55-0.440.14-0.850.53-0.85-0.81
Accounts Payable
0.510.320.41-0.85-0.620.650.49-0.23-0.210.640.210.49-0.10.020.450.720.230.040.490.36-0.010.17-0.40.580.48
Cash
0.950.360.73-0.91-0.950.650.96-0.360.490.960.530.96-0.25-0.030.750.70.05-0.080.460.36-0.210.71-0.420.920.88
Cash And Short Term Investments
1.00.430.74-0.79-0.920.490.96-0.350.510.930.61.0-0.250.020.740.660.03-0.080.450.29-0.20.77-0.420.90.85
Common Stock Total Equity
-0.33-0.35-0.070.310.4-0.23-0.36-0.35-0.18-0.39-0.39-0.340.99-0.27-0.1-0.150.160.020.00.20.24-0.34-0.05-0.21-0.17
Non Current Liabilities Total
0.520.170.2-0.17-0.45-0.210.490.51-0.180.430.550.51-0.190.130.170.180.10.010.290.320.030.66-0.350.320.4
Other Stockholder Equity
0.930.360.72-0.89-1.00.640.960.93-0.390.430.50.93-0.29-0.010.730.670.1-0.080.530.4-0.150.83-0.510.870.84
Total Liab
0.610.92-0.1-0.28-0.540.210.530.6-0.390.550.50.6-0.370.79-0.090.760.2-0.040.490.630.070.55-0.540.20.12
Total Current Assets
1.00.440.73-0.79-0.920.490.961.0-0.340.510.930.6-0.250.030.740.660.04-0.080.450.3-0.20.77-0.430.890.85
Common Stock
-0.23-0.330.030.180.31-0.1-0.25-0.250.99-0.19-0.29-0.37-0.25-0.290.0-0.060.170.010.050.240.22-0.31-0.09-0.1-0.07
Other Current Liab
0.040.88-0.640.16-0.040.02-0.030.02-0.270.13-0.010.790.03-0.29-0.630.540.18-0.050.260.580.170.1-0.34-0.39-0.49
Net Tangible Assets
0.73-0.220.99-0.76-0.70.450.750.74-0.10.170.73-0.090.740.0-0.630.19-0.11-0.060.16-0.15-0.30.5-0.080.950.96
Common Stock Shares Outstanding
0.680.790.17-0.68-0.690.720.70.66-0.150.180.670.760.66-0.060.540.190.22-0.090.580.760.00.4-0.580.450.33
Non Current Assets Total
0.120.19-0.03-0.02-0.110.230.050.030.160.10.10.20.040.170.18-0.110.220.090.870.340.960.12-0.65-0.02-0.03
Non Currrent Assets Other
-0.07-0.06-0.050.090.080.04-0.08-0.080.020.01-0.08-0.04-0.080.01-0.05-0.06-0.090.090.08-0.110.1-0.06-0.46-0.05-0.05
Good Will
0.520.440.22-0.41-0.550.490.460.450.00.290.530.490.450.050.260.160.580.870.080.590.730.49-0.860.330.29
Other Current Assets
0.330.6-0.15-0.31-0.440.360.360.290.20.320.40.630.30.240.58-0.150.760.34-0.110.590.210.4-0.660.070.02
Intangible Assets
-0.120.09-0.210.240.14-0.01-0.21-0.20.240.03-0.150.07-0.20.220.17-0.30.00.960.10.730.21-0.03-0.52-0.25-0.25
Short Long Term Debt Total
0.780.320.52-0.5-0.850.170.710.77-0.340.660.830.550.77-0.310.10.50.40.12-0.060.490.4-0.03-0.550.60.63
Property Plant And Equipment Net
-0.48-0.47-0.130.320.53-0.4-0.42-0.42-0.05-0.35-0.51-0.54-0.43-0.09-0.34-0.08-0.58-0.65-0.46-0.86-0.66-0.52-0.55-0.26-0.22
Net Invested Capital
0.890.050.94-0.87-0.850.580.920.9-0.210.320.870.20.89-0.1-0.390.950.45-0.02-0.050.330.07-0.250.6-0.260.98
Net Working Capital
0.84-0.080.96-0.82-0.810.480.880.85-0.170.40.840.120.85-0.07-0.490.960.33-0.03-0.050.290.02-0.250.63-0.220.98
Click cells to compare fundamentals

Biovie Account Relationship Matchups

High Positive Relationship

Cash And Short Term Investments
+ 1.0
Total Assets
Total Current Assets
+ 1.0
Total Assets
Total Current Assets
+ 1.0
Cash And Short Term Investments
Net Tangible Assets
+ 0.99
Total Stockholder Equity
Common Stock
+ 0.99
Common Stock Total Equity
Net Working Capital
+ 0.98
Net Invested Capital

High Negative Relationship

Other Stockholder Equity
- 1.0
Retained Earnings
Cash
- 0.95
Retained Earnings
Total Current Assets
- 0.92
Retained Earnings
Cash And Short Term Investments
- 0.92
Retained Earnings
Retained Earnings
- 0.92
Total Assets
Cash
- 0.91
Net Debt

Biovie fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.1M6.0M20.1M35.1M25.2M26.5M
Total Current Liabilities23.5M996.4K4.2M14.5M9.4M5.1M
Total Stockholder Equity(21.5M)5.1M3.7M15.3M15.5M16.3M
Net Debt873.8K(4.5M)(6.4M)(5.0M)(17.7M)(16.8M)
Retained Earnings(41.0M)(224.9M)(251.0M)(301.2M)(334.2M)(317.5M)
Accounts Payable1.3M996.4K2.4K3.5K3.6M3.8M
Cash37.2K4.5M18.6M19.5M23.8M25.0M
Cash And Short Term Investments37.2K4.5M18.6M33.9M23.8M25.0M
Common Stock Total Equity50.7K520.02.2K2.5K2.2K2.1K
Liabilities And Stockholders Equity2.1M6.0M20.1M35.1M25.2M26.5M
Non Current Liabilities Total62.5K0.012.3M5.3M349.9K332.4K
Other Stockholder Equity19.5M229.9M254.6M316.4M349.7M367.2M
Total Liab23.6M996.4K16.4M19.8M9.7M6.9M
Total Current Assets413.0K4.6M18.8M34.0M24.0M25.3M
Common Stock520.02.2K2.5K3.6K6.2K8.0K
Other Current Liab21.4M996.4K4.1M5.3M3.8K3.6K
Net Tangible Assets(23.2M)3.6M2.5M14.4M16.5M17.3M
Common Stock Shares Outstanding4.9M1.2M2.5M3.2M4.5M4.7M
Non Current Assets Total1.7M1.4M1.3M1.1M1.2M1.3M
Other Current Assets375.8K187.0K275.8K102.5K204.4K163.7K
Intangible Assets1.3M1.1M866.5K637.1K407.7K387.3K
Net Invested Capital(20.6M)5.1M15.8M29.7M34.1M35.8M
Net Working Capital(23.1M)3.6M14.6M19.5M22.5M23.6M
Capital Stock520.02.2K2.5K3.6K3.3K3.1K

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
How To Invest In Biovie
Details
Is Biovie Stock a good investment?
Details
What is Biovie's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.08)
Return On Assets
(0.67)
Return On Equity
(2.08)
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY